Pivotal Opportunity For UK Medtech Must Not Be Wasted
New regulatory and market access momentum could create building blocks for future systems
The UK continues to work on its new medtech regulatory system and market access processes for innovations, but all the planning and preparations will count for little if not accompanied by sound execution, warns Lincoln Tsang of law firm Ropes & Gray.
